Protocols & Services

Supported by a dynamic research division, NTD Labs has achieved numerous milestones in prenatal screening and immunoassay testing. These include the introduction of the Ultra-Screen® protocol for first trimester screening, Instant Risk AssessmentSM (IRA), and Fetal Nasal Bone Assessment.
These safe, non-invasive procedures have been widely accepted by leading healthcare practitioners and opinion leaders worldwide. The Ultra-Screen protocol is now considered the standard of care in first trimester Down syndrome screening, having been validated by 18 clinical studies, and 2 NIH sponsored trials, involving more than 190,000 pregnant women. (References)